tiprankstipranks
Advertisement

ECNS - ETF AI Analysis

Compare

Top Page

ECNS

iShares MSCI China Small-Cap ETF (ECNS)

Rating:55Neutral
Price Target:
ECNS, the iShares MSCI China Small-Cap ETF, has a middling overall rating that reflects a mix of solid but uneven holdings. Strong contributors like Minth Group, with healthy revenue and profitability growth supported by a positive technical trend, help support the fund’s quality, while names such as Zai Lab and Keymed Biosciences, which face ongoing losses, cash flow issues, and bearish trading momentum, weigh on the outlook. The main risk is the fund’s focus on smaller Chinese companies, where several holdings show profitability and cash flow challenges alongside weak technical trends.
Positive Factors
Strong Year-To-Date Performance
The fund has delivered positive returns so far this year, showing improving momentum after recent ups and downs.
Solid Top Holdings Performance
Many of the largest positions, including several health care and technology names, have shown strong gains this year, helping support the ETF’s overall results.
Broad Sector Diversification
The ETF spreads its investments across many sectors such as health care, technology, industrials, and consumer stocks, which can help reduce the impact of weakness in any single industry.
Negative Factors
High Geographic Concentration in Hong Kong
Most of the fund’s assets are tied to Hong Kong-listed companies, which increases exposure to local economic, regulatory, and political risks.
Recent Short-Term Volatility
The ETF has had a weak three-month stretch despite a stronger one-month rebound, suggesting that returns can be bumpy over shorter periods.
Relatively High Expense Ratio
The fund’s ongoing fee is on the higher side for an ETF, which can gradually eat into long-term returns compared with lower-cost options.

ECNS vs. SPDR S&P 500 ETF (SPY)

ECNS Summary

The iShares MSCI China Small-Cap ETF (ECNS) tracks the MSCI China Small Cap index, focusing on smaller companies in China and Hong Kong across many sectors like health care, technology, and industrials. It holds lesser-known but growing businesses such as Minth Group and Kingsoft Cloud. Someone might invest in this ETF to seek long-term growth and diversification by spreading money across many small, fast-growing Chinese companies instead of picking individual stocks. A key risk is that small-cap Chinese stocks can be very volatile and are sensitive to changes in China’s economy, regulations, and overall market conditions.
How much will it cost me?The iShares MSCI China Small-Cap ETF (ECNS) has an expense ratio of 0.59%, which means you’ll pay $5.90 per year for every $1,000 invested. This is higher than average because the fund is actively managed to focus on small-cap stocks in China, which requires more research and management compared to passively managed funds. It’s designed for investors seeking growth opportunities in a niche market.
What would affect this ETF?The iShares MSCI China Small-Cap ETF (ECNS) could benefit from China's economic growth and government support for innovation, especially in sectors like healthcare and technology, which make up a significant portion of its holdings. However, risks include potential regulatory changes in China, global economic uncertainty, and the volatility of small-cap stocks, which are more sensitive to market fluctuations. Investors should also consider how geopolitical tensions or shifts in trade policies might impact the ETF's performance.

ECNS Top 10 Holdings

ECNS is a pure China small-cap play, and its story is all about stock picking in a volatile market. On the positive side, Kingboard Laminates and Kingsoft Cloud have been rising, giving the fund a lift from industrial and tech names tied to China’s manufacturing and digital growth. Minth Group and China Everbright are also pulling their weight with steadier gains. Offsetting that, health care names like Zai Lab and Keymed Biosciences are lagging, so the fund’s tilt toward Chinese health care and tech comes with plenty of bumps alongside the upside.
Name
Company Name
Weight %
Market Value
Market Cap
Yearly Gain
Overall Rating
Kingboard Laminates Holdings2.21%$1.82MHK$106.73B315.27%
68
Neutral
Kingboard Holdings1.99%$1.64MHK$52.33B133.33%
69
Neutral
Minth Group1.97%$1.63MHK$42.03B133.17%
71
Outperform
Kingsoft Cloud Holdings Ltd1.68%$1.38MHK$38.93B37.40%
51
Neutral
China Everbright1.39%$1.15MHK$33.48B46.60%
66
Neutral
XD, Inc.1.36%$1.12MHK$32.67B93.30%
61
Neutral
Zai Lab Ltd1.22%$1.00MHK$19.93B-29.78%
42
Neutral
China Conch Venture Holdings1.19%$977.59KHK$20.72B21.62%
67
Neutral
Harbin Electric Co. Ltd. Class H1.14%$936.98KHK$50.36B331.86%
74
Outperform
Dongyue Group Limited1.13%$934.31KHK$20.37B38.60%
62
Neutral

ECNS Technical Analysis

Technical Analysis Sentiment
Negative
Last Price
Price Trends
50DMA
33.97
Negative
100DMA
34.16
Negative
200DMA
34.73
Negative
Market Momentum
MACD
-0.01
Positive
RSI
44.27
Neutral
STOCH
5.50
Positive
Evaluating momentum and price trends is crucial in ETF analysis to make informed investment decisions. For ECNS, the sentiment is Negative. The current price of undefined is equal to the 20-day moving average (MA) of 33.73, equal to the 50-day MA of 33.97, and equal to the 200-day MA of 34.73, indicating a bearish trend. The MACD of -0.01 indicates Positive momentum. The RSI at 44.27 is Neutral, neither overbought nor oversold. The STOCH value of 5.50 is Positive, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for ECNS.

ECNS Peer Comparison

Comparison Results
Name
Price
Price Target
AUM
Expense Ratio
Overall Rating
$82.61M0.59%
55
Neutral
$6.77B0.59%
58
Neutral
$6.04B0.74%
73
Outperform
$113.25M0.70%
67
Neutral
$112.43M0.80%
67
Neutral
$21.46M0.85%
67
Neutral
Performance Comparison
Ticker
Company Name
Price
Change
% Change
ECNS
iShares MSCI China Small-Cap ETF
33.32
7.55
29.30%
MCHI
iShares MSCI China ETF
FXI
iShares China Large-Cap ETF
PGJ
Invesco Golden Dragon China Etf
FCA
First Trust China AlphaDEX Fund
MJSC
MUFG Japan Small Cap Active ETF
Glossary
BuyAn ETF rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the ETF is likely to deliver higher returns compared to other ETFs in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldAn ETF rated as a "Hold" s expected to perform in line with the overall market or a specific benchmark. This rating indicates that the ETF is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellAn ETF rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the ETF may deliver lower returns compared to other ETFs in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
DisclaimerThis AI Analyst ETF Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in ETFs carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: ―
Table of Contents
Advertisement